UA
48
6
NWS
69
5
AMAT
33
3
MTCH
62
22
KHC
11
2
HAS
29
3
CHRW
53
2
HCA
37
7
LOW
42
14
SYK
50
4
EMN
40
5
HBI
53
4
AN
49
2
KEY
24
2
PH
60
5
FOX
71
3
LMT
29
-5
XRX
48
2
SIG
52
5
AMG
33
-11
UA
48
6
NWS
69
5
AMAT
33
3
MTCH
62
22
KHC
11
2
HAS
29
3
CHRW
53
2
HCA
37
7
LOW
42
14
SYK
50
4
EMN
40
5
HBI
53
4
AN
49
2
KEY
24
2
PH
60
5
FOX
71
3
LMT
29
-5
XRX
48
2
SIG
52
5
AMG
33
-11
Financhill
Back

Planet Labs PBC 10K Form

Sell
36

PL
Planet Labs PBC

Last Price:
$4.01
Seasonality Move:
-16.86%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PL News And Ratings

See the #1 stock for the next 7 days that we like better than PL

PL Financial Statistics

Sales & Book Value

Annual Sales: $220.7M
Cash Flow: $-5.1M
Price / Cash Flow: 0
Annual Sales: $1.57
Price / Book: 2.58

Profitability

EPS (TTM): -0.41000
Net Income (TTM): $-118.1M
Gross Margin: $113M
Return on Equity: -23.72%
Return on Assets: -17.48%

Planet Labs PBC Earnings Forecast

Key Planet Labs PBC Financial Ratios

  • The Gross Profit Margin over the past 5 years for PL is 51.18%.
  • The Selling, General & Administrative Expenses for PL have been equal to 75.38% of Gross Profit Margin.
  • The Research & Development expenses have been 52.71% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of PL is -63.67% of Total Revenues.
  • Per Share Earnings over the last 15 years have been positive in 9 years.

Planet Labs PBC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Professional Services
Sector: Industrials
Current Symbol: PL
Website: planet.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.34
Quick Ratio: 2.18

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PL Technical Analysis vs Fundamental Analysis

Sell
36
Planet Labs PBC (PL) is a Sell

Is Planet Labs PBC a Buy or a Sell?

  • Planet Labs PBC stock is rated a Sell
    The current Planet Labs PBC [PL] share price is $4.04. The Score for PL is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.